Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.

Trebosc V, Gartenmann S, Tötzl M, Lucchini V, Schellhorn B, Pieren M, Lociuro S, Gitzinger M, Tigges M, Bumann D, Kemmer C.

mBio. 2019 Jul 16;10(4). pii: e01083-19. doi: 10.1128/mBio.01083-19.

2.

Chemical Validation of DegS As a Target for the Development of Antibiotics with a Novel Mode of Action.

Bongard J, Schmitz AL, Wolf A, Zischinsky G, Pieren M, Schellhorn B, Bravo-Rodriguez K, Schillinger J, Koch U, Nussbaumer P, Klebl B, Steinmann J, Buer J, Sanchez-Garcia E, Ehrmann M, Kaiser M.

ChemMedChem. 2019 Jun 5;14(11):1074-1078. doi: 10.1002/cmdc.201900193. Epub 2019 Apr 24.

PMID:
30945468
3.

A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.

Trebosc V, Gartenmann S, Royet K, Manfredi P, Tötzl M, Schellhorn B, Pieren M, Tigges M, Lociuro S, Sennhenn PC, Gitzinger M, Bumann D, Kemmer C.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7263-7271. Print 2016 Dec.

4.

Vacuolar SNARE protein transmembrane domains serve as nonspecific membrane anchors with unequal roles in lipid mixing.

Pieren M, Desfougères Y, Michaillat L, Schmidt A, Mayer A.

J Biol Chem. 2015 May 15;290(20):12821-32. doi: 10.1074/jbc.M115.647776. Epub 2015 Mar 27.

5.

WITHDRAWN: Vacuolar SNARE transmembrane domains serve as non-specific membrane anchors with unequal roles in lipid mixing.

Semenov A, Pieren M, Schmidt A, Mayer A.

J Biol Chem. 2014 Apr 7. pii: jbc.M114.548479. [Epub ahead of print]

6.

Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance.

Pieren M, Tigges M.

Curr Opin Pharmacol. 2012 Oct;12(5):551-5. doi: 10.1016/j.coph.2012.07.005. Epub 2012 Jul 25. Review.

PMID:
22835931
7.

The SM protein Vps33 and the t-SNARE H(abc) domain promote fusion pore opening.

Pieren M, Schmidt A, Mayer A.

Nat Struct Mol Biol. 2010 Jun;17(6):710-7. doi: 10.1038/nsmb.1809. Epub 2010 May 9.

PMID:
20453860
8.

Structure determination of VEGF-E by sulfur SAD.

Wagner A, Pieren M, Schulze-Briese C, Ballmer-Hofer K, Prota AE.

Acta Crystallogr D Biol Crystallogr. 2006 Nov;62(Pt 11):1430-4. Epub 2006 Oct 18.

PMID:
17057349
9.

A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2.

Cébe Suarez S, Pieren M, Cariolato L, Arn S, Hoffmann U, Bogucki A, Manlius C, Wood J, Ballmer-Hofer K.

Cell Mol Life Sci. 2006 Sep;63(17):2067-77.

PMID:
16909199
10.

Crystal structure of the Orf virus NZ2 variant of vascular endothelial growth factor-E. Implications for receptor specificity.

Pieren M, Prota AE, Ruch C, Kostrewa D, Wagner A, Biedermann K, Winkler FK, Ballmer-Hofer K.

J Biol Chem. 2006 Jul 14;281(28):19578-87. Epub 2006 May 3.

11.

The use of calnexin and calreticulin by cellular and viral glycoproteins.

Pieren M, Galli C, Denzel A, Molinari M.

J Biol Chem. 2005 Aug 5;280(31):28265-71. Epub 2005 Jun 10.

12.

Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER.

Molinari M, Galli C, Piccaluga V, Pieren M, Paganetti P.

J Cell Biol. 2002 Jul 22;158(2):247-57. Epub 2002 Jul 15.

Supplemental Content

Loading ...
Support Center